NO178954C - Fremgangsmåte for fremstilling av et immunoglobulin-konjugat - Google Patents

Fremgangsmåte for fremstilling av et immunoglobulin-konjugat

Info

Publication number
NO178954C
NO178954C NO881105A NO881105A NO178954C NO 178954 C NO178954 C NO 178954C NO 881105 A NO881105 A NO 881105A NO 881105 A NO881105 A NO 881105A NO 178954 C NO178954 C NO 178954C
Authority
NO
Norway
Prior art keywords
preparing
immunoglobulin conjugate
immunoglobulin
conjugate
Prior art date
Application number
NO881105A
Other languages
English (en)
Norwegian (no)
Other versions
NO881105D0 (no
NO178954B (no
NO881105L (no
Inventor
Ian Farquhar Campbell Mckenzie
Geoffrey Allan Pietersz
Mark John Smyth
Original Assignee
Erba Carlo Spa
Univ Melbourne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Carlo Spa, Univ Melbourne filed Critical Erba Carlo Spa
Publication of NO881105D0 publication Critical patent/NO881105D0/no
Publication of NO881105L publication Critical patent/NO881105L/no
Publication of NO178954B publication Critical patent/NO178954B/no
Publication of NO178954C publication Critical patent/NO178954C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/44—Antibodies bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
    • A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
    • A61K47/6807—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug or compound being a sugar, nucleoside, nucleotide, nucleic acid, e.g. RNA antisense
    • A61K47/6809—Antibiotics, e.g. antitumor antibiotics anthracyclins, adriamycin, doxorubicin or daunomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
NO881105A 1987-03-11 1988-03-11 Fremgangsmåte for fremstilling av et immunoglobulin-konjugat NO178954C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPI080387 1987-03-11
AUPI295587 1987-07-07

Publications (4)

Publication Number Publication Date
NO881105D0 NO881105D0 (no) 1988-03-11
NO881105L NO881105L (no) 1988-09-12
NO178954B NO178954B (no) 1996-04-01
NO178954C true NO178954C (no) 1996-07-10

Family

ID=25643244

Family Applications (1)

Application Number Title Priority Date Filing Date
NO881105A NO178954C (no) 1987-03-11 1988-03-11 Fremgangsmåte for fremstilling av et immunoglobulin-konjugat

Country Status (29)

Country Link
US (1) US5798097A (sv)
JP (1) JP2736255B2 (sv)
KR (1) KR0130906B1 (sv)
CN (1) CN1045621C (sv)
AT (1) AT395375B (sv)
AU (1) AU622105B2 (sv)
BE (1) BE1001051A4 (sv)
CA (1) CA1329156C (sv)
CH (1) CH678815A5 (sv)
CZ (1) CZ281193B6 (sv)
DE (1) DE3808166C2 (sv)
DK (1) DK173792B1 (sv)
ES (1) ES2006109A6 (sv)
FI (1) FI98706C (sv)
FR (1) FR2612074B1 (sv)
GB (1) GB2203154B (sv)
GR (1) GR1000059B (sv)
HU (1) HU205266B (sv)
IE (1) IE64781B1 (sv)
IL (1) IL85688A0 (sv)
IT (1) IT8819746A0 (sv)
MY (1) MY103231A (sv)
NL (1) NL8800610A (sv)
NO (1) NO178954C (sv)
NZ (1) NZ223834A (sv)
PT (1) PT86960B (sv)
RU (1) RU2106147C1 (sv)
SE (1) SE503402C2 (sv)
YU (1) YU46858B (sv)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6824777B1 (en) 1992-10-09 2004-11-30 Licentia Ltd. Flt4 (VEGFR-3) as a target for tumor imaging and anti-tumor therapy
EP1353952B1 (en) 1994-11-14 2007-04-11 Ludwig Institute For Cancer Research Flt4(vegfr-3) as a target for tumor imaging and anti-tumor therapy
WO2000021560A1 (en) * 1998-10-09 2000-04-20 Ludwig Institute For Cancer Research Flt4 (VEGFR-3) AS A TARGET FOR TUMOR IMAGING AND ANTI-TUMOR THERAPY
EP1343531A2 (en) * 2000-12-21 2003-09-17 McGILL UNIVERSITY Conjugates of antibodies and anticancer drugs
CA2522700A1 (en) * 2003-04-18 2004-11-04 Cytovia, Inc. Methods of treating diseases responsive to induction of apoptosis and screening assays
GB0511266D0 (en) * 2005-06-02 2005-07-13 Trust Chemical compounds
US20080108138A1 (en) * 2006-06-13 2008-05-08 Vermette Patrick Bioactive compositions and their use in cell patterning
KR102099462B1 (ko) 2010-11-30 2020-04-10 제넨테크, 인크. 저친화도 혈액-뇌 장벽 수용체 항체 및 그의 용도
CA2901226C (en) 2013-02-18 2020-11-17 Vegenics Pty Limited Vascular endothelial growth factor binding proteins

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT346838B (de) * 1975-01-22 1978-11-27 Farmaceutici Italia Verfahren zur herstellung von neuen optisch aktiven anthracyclinonen
AT343811B (de) * 1975-01-22 1978-06-26 Farmaceutici Italia Verfahren zur herstellung von neuen optisch aktiven anthracyclinonen
GB1500421A (en) * 1975-01-22 1978-02-08 Farmaceutici Italia Optically active anthracyclinones
AT343812B (de) * 1975-01-22 1978-06-26 Farmaceutici Italia Verfahren zur herstellung von neuen optisch aktiven daunosaminylderivaten von anthracyclinonen
GB1511680A (en) 1975-11-18 1978-05-24 Farmaceutici Italia Daunosaminyl anthracyclinones
GB1541436A (en) * 1976-02-02 1979-02-28 Searle & Co Immunological materials
US4950738A (en) * 1984-09-13 1990-08-21 Cytogen Corporation Amine derivatives of anthracycline antibiotics
US5162512A (en) * 1982-03-09 1992-11-10 Cytogen Corporation Amine derivatives of anthracycline antibodies
US4867973A (en) * 1984-08-31 1989-09-19 Cytogen Corporation Antibody-therapeutic agent conjugates
JPS59186924A (ja) * 1983-04-08 1984-10-23 Kureha Chem Ind Co Ltd ヒト免疫グロブリン結合抗腫瘍剤
US4545985A (en) * 1984-01-26 1985-10-08 The United States Of America As Represented By The Secretary, Dept. Of Health And Human Services Pseudomonas exotoxin conjugate immunotoxins
GB8413464D0 (en) * 1984-05-25 1984-07-04 Erba Farmitalia Anthracycline-anionic polymer conjugates
JPS61155334A (ja) * 1984-12-28 1986-07-15 Teijin Ltd 殺細胞性修飾免疫グロブリン及びその製造方法
FR2584293B1 (fr) * 1985-07-04 1989-03-17 Ire Celltarg Sa Anticorps utiles comme agents de pilotage et conjugues les incorporant

Also Published As

Publication number Publication date
RU2106147C1 (ru) 1998-03-10
KR880010775A (ko) 1988-10-24
IT8819746A0 (it) 1988-03-11
JP2736255B2 (ja) 1998-04-02
DK131588A (da) 1988-09-12
AU622105B2 (en) 1992-04-02
CA1329156C (en) 1994-05-03
AU1288188A (en) 1988-09-15
NO881105D0 (no) 1988-03-11
CZ161288A3 (en) 1996-07-17
ATA67488A (de) 1992-05-15
PT86960B (pt) 1992-06-30
NZ223834A (en) 1990-05-28
FI98706C (sv) 1997-08-11
FR2612074A1 (fr) 1988-09-16
FR2612074B1 (fr) 1991-06-21
JPS63301832A (ja) 1988-12-08
PT86960A (pt) 1988-04-01
YU46858B (sh) 1994-06-24
DK173792B1 (da) 2001-11-05
CN88101810A (zh) 1988-11-09
ES2006109A6 (es) 1989-04-01
SE8800886D0 (sv) 1988-03-11
SE503402C2 (sv) 1996-06-10
FI98706B (sv) 1997-04-30
IL85688A0 (en) 1988-08-31
HU205266B (en) 1992-04-28
NL195078C (sv) 2003-07-30
FI881158A0 (sv) 1988-03-11
YU48288A (en) 1989-08-31
KR0130906B1 (ko) 1998-04-23
IE880701L (en) 1988-09-11
DE3808166A1 (de) 1988-09-22
BE1001051A4 (fr) 1989-06-20
NO178954B (no) 1996-04-01
CZ281193B6 (cs) 1996-07-17
NL8800610A (nl) 1988-10-03
GB2203154A (en) 1988-10-12
FI881158A (sv) 1988-09-12
GR880100148A (en) 1989-01-31
GB2203154B (en) 1991-06-26
GB8805865D0 (en) 1988-04-13
CN1045621C (zh) 1999-10-13
HUT46547A (en) 1988-11-28
CH678815A5 (sv) 1991-11-15
GR1000059B (el) 1990-06-27
DE3808166C2 (de) 1997-08-28
DK131588D0 (da) 1988-03-11
NO881105L (no) 1988-09-12
SE8800886L (sv) 1989-09-12
IE64781B1 (en) 1995-09-06
US5798097A (en) 1998-08-25
AT395375B (de) 1992-12-10
MY103231A (en) 1993-05-29

Similar Documents

Publication Publication Date Title
PT88596A (pt) Process for preparing 2-anilinopyrimidine derivatives useful aspesticidas
PT86866A (pt) Process for preparing piperazinyl-heterocyclic compounds
PT87273A (pt) Process for preparing substituted quinolones
ES543653A0 (es) Procedimiento de preparar derivados de 1,4-dihidropiridinas
NO173312C (no) Fremgangsm}te for fremstilling av n{ringsmidler
NO176758C (no) Analogifremgangsmåte for fremstilling av terapeutiske anvendbare tetrazolyl-bifenylylmetyl-pyrimidiner
PT84932A (en) Process for preparing immunoglobulin conjugates
PT86687A (pt) Process for the preparation of novel polyamine derivatives
NO176922C (no) Fremgangsmåte for fremstilling av bifunksjonelle proteiner
NO172447C (no) Fremgangsmaate for fremstilling av b-avermectiner
PT87218A (pt) Process for preparing substituted pyrroles
PT88447A (pt) Improved process for preparing gelatine capsules
NO178954C (no) Fremgangsmåte for fremstilling av et immunoglobulin-konjugat
NO171910C (no) Fremgangsmaate for fremstilling av 1-alkyl-5-nitroimidazoler
YU198989A (en) Process for obtaining quinolynic derivatives
PT86643A (pt) Method for measuring anti-dna antibodies
NO885435D0 (no) Fremgangsmaate for fremstilling av benzotiazepinderivater.
PT87359A (pt) Process for the preparation of pyrrolidine derivatives
NO883339D0 (no) Fremgangsmaate for fremstilling av benzimidazol-2-yl-pyridiniumforbindelser.
NO851386L (no) Fremgangsmaate for fremstilling av antigen.
NO833655L (no) Fremgangsmaate for fremstilling av antigen
NO880992D0 (no) Fremgangsmaate for fremstilling av pyridinderivater.
PT87732A (pt) Process for the preparation of (e)-(p-fluorophenethyl)-3-fluoroallylamine
NO172095C (no) Framgangsmaate for framstilling av sondenaering
YU110888A (en) Process for obtaining timine derivatives

Legal Events

Date Code Title Description
MK1K Patent expired